At a glance
ClinicalIndex Comparison RecordN/ACompleted· 471 enrolled
Drug / intervention
Attain Stability Quad Left Ventricular Pacing Leaddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Attain Stability™ Quad Clinical Study
In Brief
A clinical study evaluating Attain Stability Quad Left Ventricular Pacing Lead for Heart Failure. Completed, enrolled 471 participants across 50 sites in 10 countries.
Detailed Summary
The purpose of this clinical study is to evaluate the safety and efficacy of the Attain Stability Quadripolar MRI SureScan Left Ventricular (LV) lead (Model 4798).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesCanada, Germany, Hong Kong, Italy, Malaysia, Netherlands, Norway, Spain, Sweden, United States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 2017
Enrollment StartJul 2017
Primary CompletionAug 2018
Study CompletionMay 2019
TodayJul 2026
First PostedApr 4, 2017
Enrollment StartJul 7, 2017
Primary CompletionAug 2, 2018
Study CompletionMay 31, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.2 years ago
Interventions
Attain Stability Quad Left Ventricular Pacing Leaddevice
cardiac stimulation